Coriell Institute

Coriell Institute

The Coriell Institute is an independent nonprofit biomedical research organization based in Camden, New Jersey that maintains human biorepositories, conducts translational research, and supports clinical and population studies. Founded in 1953 with roots tied to public figures and institutional partners, the institute has collaborated with federal agencies, academic centers, and private foundations to enable work in human genetics, pharmacogenomics, and rare disease research. Its collections and programs have been used by investigators at universities, corporations, and international consortia.

History

The institute originated in the 1950s amid postwar public health initiatives involving figures such as Eleanor Roosevelt and institutions including National Institutes of Health and Wistar Institute. Early activities connected to projects led by researchers associated with Cold Spring Harbor Laboratory, Rockefeller University, University of Pennsylvania, and clinical centers in Philadelphia. During the late 20th century, it expanded through partnerships with agencies like Centers for Disease Control and Prevention, Food and Drug Administration, and collaborations with industry partners including Roche, Pfizer, GlaxoSmithKline, and Merck. The institute's archive and sample stewardship supported consortia such as the Human Genome Project, International HapMap Project, 1000 Genomes Project, and initiatives linked to National Human Genome Research Institute and Wellcome Trust. Governance and strategic growth involved interactions with philanthropic entities like the Gates Foundation, Howard Hughes Medical Institute, Robert Wood Johnson Foundation, and state programs in New Jersey. Over decades, the institute partnered with academic programs at Princeton University, Rutgers University, Temple University, Drexel University, and hospital systems like Cooper University Health Care.

Research and Programs

Research at the institute spans human genetics, cytogenetics, cell biology, and translational initiatives connected to precision medicine consortia including All of Us Research Program, Precision Medicine Initiative, Global Alliance for Genomics and Health, and disease-focused networks like Undiagnosed Diseases Network and Rare Diseases Clinical Research Network. Projects have involved techniques developed at labs such as Broad Institute, Sanger Institute, Genentech, and academic groups at Harvard Medical School, Stanford University School of Medicine, Johns Hopkins University, and Columbia University Irving Medical Center. The institute's programs support genomic data sharing consistent with standards from Clinical Laboratory Improvement Amendments, College of American Pathologists, and policy frameworks influenced by HIPAA and initiatives by National Academy of Medicine. Scientific collaborations include translational studies with centers like Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, UCSF, and biotechnology firms including Illumina, Thermo Fisher Scientific, Agilent Technologies, Qiagen, and 10x Genomics.

Coriell Biorepository Collections

The institute manages human biospecimen collections used by investigators from institutions such as Yale University, Columbia University, University of Chicago, Northwestern University', University of Michigan, University of California, Los Angeles, and international partners including University of Oxford, Karolinska Institutet, University of Toronto, and Max Planck Society. Collections support repositories used in studies by consortia like GTEx Consortium, Alzheimer's Disease Sequencing Project, Cancer Genome Atlas, PsychENCODE, and ENIGMA Consortium. Sample types and derived materials have enabled research connected to clinical laboratories at Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Fred Hutchinson Cancer Center, and programs funded by National Cancer Institute, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The biorepository distributes cell lines and DNA used by projects at Wellcome Sanger Institute, European Molecular Biology Laboratory, Cold Spring Harbor Laboratory, and biotech startups spun out with investors such as Sequoia Capital and Kleiner Perkins. Material access policies reflect standards promoted by Global Alliance for Genomics and Health and ethics guidance from World Health Organization and Council for International Organizations of Medical Sciences.

Education and Outreach

Educational initiatives have included partnerships with schools and programs at Rutgers University Camden, Camden County College, Project Lead The Way, and community health organizations such as Camden Coalition of Healthcare Providers. Outreach activities aligned with networks like National Society of Genetic Counselors, American Society of Human Genetics, American Association for Cancer Research, Society for Neuroscience, and public science programs connected to Smithsonian Institution and New Jersey Historical Society. Training programs and workshops have collaborated with graduate programs at Penn State University, Drexel University School of Medicine, Temple University School of Medicine, and international training through European Society of Human Genetics and African Society of Human Genetics. Public engagement included exhibits and talks at venues such as Liberty Science Center, The Franklin Institute, and conferences hosted by BIO International Convention and American Association for the Advancement of Science.

Governance and Funding

The organization is governed by a board with affiliations to academic and medical institutions including Princeton University, Rutgers University, University of Pennsylvania Health System, Thomas Jefferson University, and philanthropic leaders associated with foundations like Robert Wood Johnson Foundation and Bill & Melinda Gates Foundation. Funding sources have comprised federal awards from National Institutes of Health, contracts from Centers for Disease Control and Prevention, grants from National Science Foundation, and philanthropic support from entities such as Howard Hughes Medical Institute and corporate partnerships with companies like Illumina and Thermo Fisher Scientific. Financial oversight and regulatory compliance align with standards set by Internal Revenue Service, accreditation bodies like College of American Pathologists, and grant administration practices common to National Institutes of Health awards.

Category:Biobanks Category:Medical research institutes in the United States